高强度聚焦超音波 (HIFU) 市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024 年全球高强度聚焦超音波 (HIFU) 市值为 2.371 亿美元，预计到 2034 年将以 5.4% 的复合年增长率增长至 3.967 亿美元。 HIFU 是一种非侵入性治疗方法，已获得 FDA 批准用于治疗肿瘤和震颤等各种慢性疾病。 HIFU 的普及归功于它无需切口或长时间恢復即可治疗患者。随着人们对非侵入性治疗方案的认识不断提高以及癌症等疾病发病率的上升，预计未来几年全球对 HIFU 的需求将激增。患者和医疗保健提供者都越来越倾向于选择能够最大限度降低手术风险、减少住院时间并缩短恢復时间的疗法——这些因素强烈支持高强度聚焦超音波 (HIFU) 技术的应用。

此外，随着全球医疗保健体系强调早期发现和标靶治疗，HIFU因其能够精准破坏肿瘤组织而不损伤周围健康结构，成为极具吸引力的解决方案。 HIFU的应用范围不断扩展，超越肿瘤领域，例如子宫肌瘤、前列腺疾病和神经系统疾病的治疗，进一步提升了其市场潜力。影像引导、即时监测以及与机器人平台整合的进步，正在提升HIFU的临床疗效和可近性。此外，主要市场加大研发投入，以及监管机构的积极审批，预计将加速下一代HIFU系统的开发和商业化。

2024年，摄护腺癌细分市场收入达6,030万美元。人们对早期诊断的认识不断提高以及高强度聚焦超音波（HIFU）技术的进步，显着促进了该细分市场的扩张。 HIFU已成为手术和放射治疗等传统疗法的微创替代方案，其恢復期更短，副作用更少。这些优势使其成为患者和医护人员的首选治疗方案。持续的研发投入，致力于提高HIFU系统的精准度和有效性，进一步促进了此细分市场的成长。

依终端用户划分，市场分为医院、影像中心和其他领域。 2024年，医院领域占最大份额，达57.7%。医院提供全面的治疗选择，使其成为HIFU治疗的主要场所。 HIFU在儿童和成人等不同年龄层中的广泛接受度和有效性，进一步巩固了其在这些医疗机构中的应用。此外，医院基础设施投资的不断增加，以及FDA和CE等监管机构对HIFU设备的批准，也推动了该领域的进一步成长。

2024年，美国高强度聚焦超音波 (HIFU) 市场规模达8,380万美元。美国前列腺癌的高发生率，加上其先进的医疗基础设施，正在推动对HIFU等非侵入性治疗方案的需求。严格的监管环境，加上医疗创新领域不断增加的投资，正推动这项技术的普及，确保未来几年市场持续扩张。

一些知名公司正在积极塑造高强度聚焦超音波 (HIFU) 产业的竞争格局。主要参与者包括 Sonablate、Profound Medical、EDAP TMS、Insightec、重庆海扶医疗科技、ULTRAISER、ILJIN Holdings、Verasonics、Theraclion、FUSMobile、Lynton Lasers、EpiSonic 和 EpiSonic。这些参与者正在策略性地投资于产品创新、临床研究和全球扩张，以维持和扩大其市场地位。为了巩固市场地位，HIFU 产业的公司正在采取几项关键策略。这些包括将其临床应用组合从肿瘤学扩展到神经病学、妇科和泌尿科。他们正在与医院和研究机构建立合作伙伴关係，以验证和商业化 HIFU 技术的新用例。此外，许多参与者正专注于向非侵入性疗法越来越受欢迎的新兴市场进行地理扩张。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 慢性病发生率上升
    • 增加监管批准和报销政策
    • 非侵入性疗法日益受到青睐
    • 扩大在非癌症疾病的应用
  • 产业陷阱与挑战
    • 设备和手术成本高昂
• 成长潜力分析
• 监管格局
  • 我们
  • 欧洲
• 技术格局
• 未来市场趋势
• 差距分析
• LIFU 的新兴和研究应用
• 波特的分析
• PESTEL分析

第四章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第五章：市场估计与预测：按应用，2021 年至 2034 年

• 主要趋势
• 子宫肌瘤
• 摄护腺癌
• 特发性震颤
• 皮肤科
• 乳癌
• 青光眼
• 背痛
• 其他应用

第六章：市场估计与预测：依最终用途，2021 年至 2034 年

• 主要趋势
• 医院
• 影像中心
• 其他最终用途

第七章：市场估计与预测：按地区，2021 年至 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋

第八章：公司简介

• Chongqing Haifu Medical Technology
• EDAP TMS
• EpiSonic
• FUSMobile
• Insightec
• ILJIN Holdings
• Lynton Lasers
• Profound Medical
• Sonablate
• Theraclion
• ULTRAISER
• Verasonics

The Global High Intensity Focused Ultrasound (HIFU) Market was valued at USD 237.1 million in 2024 and is estimated to grow at a CAGR of 5.4% to reach USD 396.7 million by 2034. HIFU is a non-invasive treatment that has gained FDA approval for addressing various chronic conditions, including tumors and tremors. The growing adoption of HIFU is attributed to its ability to treat patients without the need for incisions or long recovery times. With increasing awareness of non-invasive treatment options and the rising prevalence of conditions like cancer, the demand for HIFU is expected to surge globally in the coming years. Patients and healthcare providers alike are showing a growing preference for therapies that minimize surgical risks, reduce hospital stays, and offer faster recovery times-factors that strongly favor the adoption of high-intensity focused ultrasound (HIFU) technologies.

Additionally, as global healthcare systems emphasize early detection and targeted treatment, HIFU presents a compelling solution due to its precision in destroying tumor tissues without damaging surrounding healthy structures. The expanding applications of HIFU beyond oncology, such as in the treatment of uterine fibroids, prostate disorders, and neurological conditions, further boost its market potential. Advancements in imaging guidance, real-time monitoring, and integration with robotic platforms are enhancing HIFU's clinical efficacy and accessibility. Moreover, increased investments in research and favorable regulatory approvals across key markets are expected to accelerate the development and commercialization of next-generation HIFU systems.

The prostate cancer segment generated USD 60.3 million in 2024. Increased awareness around early diagnosis and advancements in HIFU technology have significantly contributed to the segment's expansion. HIFU had emerged as a minimally invasive alternative to conventional treatments like surgery and radiation therapy, offering shorter recovery periods and fewer side effects. These benefits have positioned it as a preferred option for both patients and medical professionals. The segment's growth was further reinforced by continuous research and development initiatives focused on improving the accuracy and effectiveness of HIFU systems.

By end-user, the market is divided into hospitals, imaging centers, and other sectors. In 2024, the hospital segment accounted for the largest share of 57.7%. Hospitals provide comprehensive therapeutic options, making them the primary location for HIFU treatments. The wide acceptance and effectiveness of HIFU across various age groups, including children and adults, has further reinforced its use in these healthcare settings. Moreover, increasing investments in hospital infrastructure and the approval of HIFU devices by regulatory bodies such as the FDA and CE drive further growth within this segment.

U.S. High Intensity Focused Ultrasound (HIFU) Market generated USD 83.8 million in 2024. The high incidence of prostate cancer in the U.S., coupled with the country's advanced healthcare infrastructure, is fueling demand for non-invasive treatment options like HIFU. The strong regulatory environment, combined with increasing investment in healthcare innovations, is contributing to the growing adoption of this technology, ensuring continued market expansion in the coming years.

Several prominent companies are actively shaping the competitive landscape of the High-Intensity Focused Ultrasound (HIFU) Industry. Key participants include Sonablate, Profound Medical, EDAP TMS, Insightec, Chongqing Haifu Medical Technology, ULTRAISER, ILJIN Holdings, Verasonics, Theraclion, FUSMobile, Lynton Lasers, EpiSonic, and EpiSonic. These players are strategically investing in product innovation, clinical research, and global expansion to maintain and grow their market positions. To strengthen their market foothold, companies in the HIFU industry are adopting several key strategies. These include expanding their clinical application portfolio beyond oncology to include neurology, gynecology, and urology. They are forming partnerships with hospitals and research institutes to validate and commercialize new use cases for HIFU technology. Furthermore, many players are focusing on geographical expansion into emerging markets where non-invasive therapies are gaining traction.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Application
  • 2.2.2 End use
  • 2.2.3 Regional

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising incidence of chronic diseases
    • 3.2.1.2 Increasing regulatory approvals and reimbursement policies
    • 3.2.1.3 Increasing preference for non-invasive therapies
    • 3.2.1.4 Expanding applications in non-cancer diseases
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of equipment and procedures
• 3.3 Growth potential analysis
  • 3.3.1 By application
  • 3.3.2 By end use
• 3.4 Regulatory landscape
  • 3.4.1 U.S.
  • 3.4.2 Europe
• 3.5 Technology landscape
• 3.6 Future market trends
• 3.7 Gap analysis
• 3.8 Emerging and investigational applications of LIFU
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Uterine fibroids
• 5.3 Prostate cancer
• 5.4 Essential tremor
• 5.5 Dermatology
• 5.6 Breast cancer
• 5.7 Glaucoma
• 5.8 Backpain
• 5.9 Other applications

Chapter 6 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Hospitals
• 6.3 Imaging centers
• 6.4 Other end use

Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 India
  • 7.4.3 Japan
  • 7.4.4 Australia
  • 7.4.5 South Korea
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
• 7.6 Middle East and Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 South Africa
  • 7.6.3 UAE

Chapter 8 Company Profiles

• 8.1 Chongqing Haifu Medical Technology
• 8.2 EDAP TMS
• 8.3 EpiSonic
• 8.4 FUSMobile
• 8.5 Insightec
• 8.6 ILJIN Holdings
• 8.7 Lynton Lasers
• 8.8 Profound Medical
• 8.9 Sonablate
• 8.10 Theraclion
• 8.11 ULTRAISER
• 8.12 Verasonics